RE: Market Cap25 Sep 2025 14:57
Think they are on the cusp of delivery according to the RNS, what gives this credence is the fact that ALL BoD are investing own cash of £85k….probably first time it’s happened here RNS extract:
‘The net proceeds of the Fundraising (assuming the Minimum Proceeds are raised) are expected to be used as follows.
· Supporting continued near-term commercialisation & market expansion activities in UK, Europe & Middle East region (both tests).
· FDA 510(k) submission for CYP2C19 anticipated early-2026, with 3-4 month review period.
· Manufacture scale-up and efficiencies.
· User-led on-market refinements to product usability features.
· Translation of IP to include laboratory platform CYP2C19 genotyping assay in addition to point of care.’